ツムラの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2020/12/07 | 3,150 | 3,150 | 3,115 | 3,120 | ±0 | ±0% | 90,500 |
| 2020/12/04 | 3,100 | 3,125 | 3,080 | 3,120 | +25 | +0.8% | 88,500 |
| 2020/12/03 | 3,100 | 3,115 | 3,050 | 3,095 | +5 | +0.2% | 135,300 |
| 2020/12/02 | 3,130 | 3,140 | 3,070 | 3,090 | -15 | -0.5% | 169,400 |
| 2020/12/01 | 3,105 | 3,125 | 3,060 | 3,105 | +60 | +2% | 169,800 |
| 2020/11/30 | 3,205 | 3,210 | 3,040 | 3,045 | -145 | -4.5% | 215,500 |
| 2020/11/27 | 3,150 | 3,200 | 3,135 | 3,190 | +35 | +1.1% | 216,300 |
| 2020/11/26 | 3,155 | 3,170 | 3,120 | 3,155 | -30 | -0.9% | 193,900 |
| 2020/11/25 | 3,240 | 3,240 | 3,175 | 3,185 | -50 | -1.5% | 153,000 |
| 2020/11/24 | 3,235 | 3,250 | 3,195 | 3,235 | -45 | -1.4% | 208,100 |
| 2020/11/20 | 3,270 | 3,290 | 3,260 | 3,280 | -15 | -0.5% | 139,300 |
| 2020/11/19 | 3,330 | 3,330 | 3,275 | 3,295 | -35 | -1.1% | 162,100 |
| 2020/11/18 | 3,335 | 3,345 | 3,295 | 3,330 | -20 | -0.6% | 150,000 |
| 2020/11/17 | 3,345 | 3,360 | 3,295 | 3,350 | -20 | -0.6% | 120,600 |
| 2020/11/16 | 3,340 | 3,390 | 3,310 | 3,370 | +15 | +0.4% | 166,700 |
| 2020/11/13 | 3,380 | 3,380 | 3,310 | 3,355 | -25 | -0.7% | 147,300 |
| 2020/11/12 | 3,375 | 3,390 | 3,335 | 3,380 | +20 | +0.6% | 132,400 |
| 2020/11/11 | 3,390 | 3,390 | 3,335 | 3,360 | +25 | +0.7% | 184,100 |
| 2020/11/10 | 3,425 | 3,440 | 3,335 | 3,335 | -40 | -1.2% | 186,600 |
| 2020/11/09 | 3,390 | 3,410 | 3,365 | 3,375 | +10 | +0.3% | 127,800 |
| 2020/11/06 | 3,300 | 3,385 | 3,285 | 3,365 | +110 | +3.4% | 213,300 |
| 2020/11/05 | 3,230 | 3,265 | 3,215 | 3,255 | +55 | +1.7% | 184,300 |
| 2020/11/04 | 3,165 | 3,200 | 3,130 | 3,200 | +105 | +3.4% | 243,400 |
| 2020/11/02 | 3,095 | 3,135 | 3,075 | 3,095 | +30 | +1% | 110,200 |
| 2020/10/30 | 3,110 | 3,115 | 3,060 | 3,065 | -45 | -1.4% | 122,200 |
| 2020/10/29 | 3,095 | 3,130 | 3,095 | 3,110 | +5 | +0.2% | 73,000 |
| 2020/10/28 | 3,075 | 3,110 | 3,055 | 3,105 | -5 | -0.2% | 88,000 |
| 2020/10/27 | 3,125 | 3,125 | 3,075 | 3,110 | -25 | -0.8% | 73,300 |
| 2020/10/26 | 3,145 | 3,180 | 3,115 | 3,135 | -20 | -0.6% | 72,400 |
| 2020/10/23 | 3,155 | 3,170 | 3,150 | 3,155 | -10 | -0.3% | 67,800 |
| 2020/10/22 | 3,185 | 3,195 | 3,155 | 3,165 | -55 | -1.7% | 94,000 |
| 2020/10/21 | 3,215 | 3,260 | 3,215 | 3,220 | +20 | +0.6% | 122,600 |
| 2020/10/20 | 3,225 | 3,230 | 3,200 | 3,200 | -10 | -0.3% | 128,100 |
| 2020/10/19 | 3,180 | 3,240 | 3,170 | 3,210 | +55 | +1.7% | 161,600 |
| 2020/10/16 | 3,130 | 3,170 | 3,120 | 3,155 | -45 | -1.4% | 153,200 |
| 2020/10/15 | 3,235 | 3,240 | 3,185 | 3,200 | -70 | -2.1% | 150,600 |
| 2020/10/14 | 3,270 | 3,305 | 3,260 | 3,270 | -40 | -1.2% | 170,500 |
| 2020/10/13 | 3,300 | 3,325 | 3,270 | 3,310 | +10 | +0.3% | 136,900 |
| 2020/10/12 | 3,310 | 3,315 | 3,265 | 3,300 | -40 | -1.2% | 140,400 |
| 2020/10/09 | 3,335 | 3,365 | 3,295 | 3,340 | +5 | +0.1% | 156,900 |
| 2020/10/08 | 3,340 | 3,350 | 3,295 | 3,335 | ±0 | ±0% | 160,000 |
| 2020/10/07 | 3,310 | 3,350 | 3,290 | 3,335 | -5 | -0.1% | 193,200 |
| 2020/10/06 | 3,305 | 3,365 | 3,290 | 3,340 | +35 | +1.1% | 164,500 |
| 2020/10/05 | 3,305 | 3,350 | 3,285 | 3,305 | +55 | +1.7% | 149,900 |
| 2020/10/02 | 3,275 | 3,285 | 3,210 | 3,250 | - | - | 293,300 |
| 2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2020/09/30 | 3,360 | 3,360 | 3,275 | 3,275 | -65 | -1.9% | 202,800 |
| 2020/09/29 | 3,335 | 3,350 | 3,265 | 3,340 | -30 | -0.9% | 203,500 |
| 2020/09/28 | 3,325 | 3,375 | 3,320 | 3,370 | +80 | +2.4% | 297,400 |
| 2020/09/25 | 3,300 | 3,350 | 3,280 | 3,290 | +10 | +0.3% | 297,600 |
1101～
1150
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「ツムラ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ツムラ | 333,200円 | +3.8% | -19.9% | 4.08% | 10.90倍 | 0.83倍 |
|
医療用漢方薬で国内シェア８割超。高齢者、がん支持療法、女性関連の３領域を重点に市場深耕 |
| 久光薬 | 407,800円 | +5.8% | +1.2% | 2.94% | 13.52倍 | 1.08倍 |
|
貼る鎮痛消炎剤首位。医療用シェア５割。大衆薬「サロンパス」で有名。米国、中国など海外強化 |
| 住友ファーマ | 80,400円 | -11.0% | +206.6% | 0.00% | 7.99倍 | 1.88倍 |
|
医薬品準大手、住友化学傘下。買収で米国へ展開。研究開発は精神神経、がん、再生細胞に重点 |
| 日本新薬 | 353,400円 | +8.0% | -15.3% | 3.51% | 9.92倍 | 0.96倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
| サンバイオ | 338,000円 | - | - | 0.00% | - | 156.55倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
市場注目の銘柄
チャート関連のコラム
